Hydroxamate inhibitors of interleukin-1.beta. converting enzyme
US5919790A · kind A · utility
25Cited by
1References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 1997 |
| Grant date | Jul 6, 1999 |
| Priority date | — |
| Expiry date | Oct 2, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/34
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula II ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.